Instituto Investigacion Sanitaria Fundacion Jimenez Diaz
Madrid, 28040, Spain
NCT Number: NCT03433521
Published data regarding the temporal pattern of AML are scarce and old. The greater knowledge of these neoplasias has made that their classification has been remarkable modified. Therefore, we consider relevant to carry out the present study as it would allow us to analyze the potential existence of a spatio-temporal pattern in the incidence of AML in Spain.
Looking for future studies?
Notify MeAll sexes
Observational
Madrid, 28040, Spain
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients with a first diagnostic of AML between 2004 and 2014.
.
Time frame: 10 years
Diagnosis of de-novo AML
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03573024
Acute Myeloid Leukemia, Hematologic Diseases
Aurora, Colorado, United States
View Trial DetailsNCT06006403
Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm
Taiyuan, Shanxi, China
View Trial DetailsNCT02971397
Acute Myeloid Leukemia, Hematologic Diseases
Winston-Salem, North Carolina, United States
View Trial DetailsNCT03836209
Acute Myeloid Leukemia, Hematologic Diseases
Scottsdale, Arizona, United States
View Trial Details